• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中东地区丙型肝炎的流行病学

Epidemiology of hepatitis C in the Middle East.

作者信息

Fallahian Farahnaz, Najafi Atabak

机构信息

Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Saudi J Kidney Dis Transpl. 2011 Jan;22(1):1-9.

PMID:21196607
Abstract

The epidemiology of hepatitis C virus (HCV) infection is not well defined in the Middle East region. A review of the epidemiology and modes of transmission and spread of HCV infection in regions located in the Middle East, including Iran, Bahrain, Iraq, Oman, Qatar, Jordan, Kuwait, Saudi Arabia, United Arab Emirates, Cyprus, Sudan, Egypt, Pakistan, Syria, Turkey, Lebanon, Gaza Strip and West Bank, and Yemen, was undertaken. Public health strategies, well-programmed, population-based and certain HCV infection at-risk surveys, and transmission risk factors' settings detection are insufficient in some countries of this region. Since significant differences in prevalence and epidemiology of HCV exist among the Middle East countries or even inside the countries, control strategies should take these differences into account.

摘要

丙型肝炎病毒(HCV)感染的流行病学在中东地区尚未得到明确界定。对中东地区包括伊朗、巴林、伊拉克、阿曼、卡塔尔、约旦、科威特、沙特阿拉伯、阿拉伯联合酋长国、塞浦路斯、苏丹、埃及、巴基斯坦、叙利亚、土耳其、黎巴嫩、加沙地带和西岸以及也门在内的HCV感染的流行病学、传播方式和扩散情况进行了综述。该地区一些国家的公共卫生策略、规划良好的基于人群的特定HCV感染风险调查以及传播风险因素的检测设置不足。由于中东国家之间甚至国家内部HCV的流行率和流行病学存在显著差异,控制策略应考虑到这些差异。

相似文献

1
Epidemiology of hepatitis C in the Middle East.中东地区丙型肝炎的流行病学
Saudi J Kidney Dis Transpl. 2011 Jan;22(1):1-9.
2
Systematic overview of hepatitis C infection in the Middle East and North Africa.中东和北非地区丙型肝炎感染的系统综述。
World J Gastroenterol. 2018 Jul 21;24(27):3038-3054. doi: 10.3748/wjg.v24.i27.3038.
3
Status of HIV and hepatitis C virus infections among prisoners in the Middle East and North Africa: review and synthesis.中东和北非地区囚犯中艾滋病毒和丙型肝炎病毒感染状况:综述与综合分析
J Int AIDS Soc. 2016 May 27;19(1):20873. doi: 10.7448/IAS.19.1.20873. eCollection 2016.
4
SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis.中东和北非地区的 SARS-CoV-2 监测:纵向趋势分析。
J Med Internet Res. 2021 Jan 15;23(1):e25830. doi: 10.2196/25830.
5
The Middle East population puzzle.中东人口之谜。
Popul Bull. 1993 Jul;48(1):1-40.
6
Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis.中东地区血液透析患者丙型肝炎病毒感染的患病率:一项系统评价和荟萃分析。
World J Gastroenterol. 2017 Jan 7;23(1):151-166. doi: 10.3748/wjg.v23.i1.151.
7
Population policies vary in Middle East.中东地区的人口政策各不相同。
Popul Today. 1993 Apr;21(4):3, 10.
8
Hepatitis C virus genotypes in the Middle East and North Africa: Distribution, diversity, and patterns.中东和北非的丙型肝炎病毒基因型:分布、多样性和模式。
J Med Virol. 2018 Jan;90(1):131-141. doi: 10.1002/jmv.24921. Epub 2017 Sep 12.
9
Molecular mechanisms and prevalence of colistin resistance of Klebsiella pneumoniae in the Middle East region: A review over the last 5 years.中东地区肺炎克雷伯菌对黏菌素耐药的分子机制及流行率:对过去 5 年的综述。
J Glob Antimicrob Resist. 2020 Sep;22:625-630. doi: 10.1016/j.jgar.2020.06.009. Epub 2020 Jun 23.
10
Expanded programme on immunization (EPI). Immunization schedules in the WHO eastern Mediterranean region, 1995.扩大免疫规划(EPI)。1995年世界卫生组织东地中海区域免疫接种时间表。
Wkly Epidemiol Rec. 1996 Jun 7;71(23):173-6.

引用本文的文献

1
COVID-19 impact on blood donor characteristics and seroprevalence of transfusion-transmitted infections in southern Thailand between 2018 and 2022.2018 年至 2022 年期间,COVID-19 对泰国南部献血者特征和输血传播感染血清阳性率的影响。
Sci Rep. 2024 Apr 4;14(1):7920. doi: 10.1038/s41598-024-57584-z.
2
Prevalence of Transfusion-Transmitted Infections (HCV, HIV, Syphilis and Malaria) in Blood Donors: A Large-Scale Cross-Sectional Study.献血者中输血传播感染(丙型肝炎病毒、人类免疫缺陷病毒、梅毒和疟疾)的患病率:一项大规模横断面研究。
Pathogens. 2022 Jun 26;11(7):726. doi: 10.3390/pathogens11070726.
3
Variable Proportions of Phylogenetic Clustering and Low Levels of Antiviral Drug Resistance among the Major HBV Sub-Genotypes in the Middle East and North Africa.
中东和北非主要乙肝病毒亚基因型中系统发育聚类的可变比例及低水平抗病毒药物耐药性
Pathogens. 2021 Oct 15;10(10):1333. doi: 10.3390/pathogens10101333.
4
Frequency of Hepatitis C Virus Genotypes in Patients Who Had Hepatocellular Carcinoma in Gastroenterological Hospitals of Tabriz.大不里士胃肠病医院肝细胞癌患者中丙型肝炎病毒基因型的频率
J Gastrointest Cancer. 2021 Mar;52(1):145-149. doi: 10.1007/s12029-020-00367-2.
5
Quantitative Structure-Activity Relationship Model for HCVNS5B inhibitors based on an Antlion Optimizer-Adaptive Neuro-Fuzzy Inference System.基于蚁狮优化器-自适应神经模糊推理系统的 HCVNS5B 抑制剂定量构效关系模型。
Sci Rep. 2018 Jan 24;8(1):1506. doi: 10.1038/s41598-017-19122-y.
6
The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses.伊朗丙型肝炎病毒的流行病学:系统评价和荟萃分析。
Sci Rep. 2018 Jan 9;8(1):150. doi: 10.1038/s41598-017-18296-9.
7
Seropositivity of Hepatitis B and C among Syrian Multi-transfused Patients with Hemoglobinopathy.叙利亚多次输血的血红蛋白病患者中乙型和丙型肝炎的血清学阳性情况。
Mediterr J Hematol Infect Dis. 2016 Sep 1;8(1):e2016046. doi: 10.4084/MJHID.2016.046. eCollection 2016.
8
Hepatitis B and C prevalence among hemodialysis patients in the West Bank hospitals, Palestine.巴勒斯坦约旦河西岸医院血液透析患者中乙型和丙型肝炎的患病率。
BMC Infect Dis. 2016 Feb 1;16:41. doi: 10.1186/s12879-016-1359-8.
9
Hepatitis C Seroprevalence and Risk Factors in Adult Population of Chaharmahal and Bakhtiari Province of Iran in 2013.2013年伊朗恰哈马哈勒-巴赫蒂亚里省成年人群丙型肝炎血清流行率及危险因素
J Clin Diagn Res. 2015 Oct;9(10):LC13-7. doi: 10.7860/JCDR/2015/14986.6694. Epub 2015 Oct 1.
10
Epidemiology of hepatitis C virus in Iran.伊朗丙型肝炎病毒的流行病学
World J Gastroenterol. 2015 Oct 14;21(38):10790-810. doi: 10.3748/wjg.v21.i38.10790.